Garcia Xiomara, Pye Sherry, Tang Xinyu, Gossett Jeffrey, Prodhan Parthak, Bhutta Adnan
Pediatric Critical Care Medicine and Cardiology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States.
Pediatric Cardiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States.
J Pediatr Intensive Care. 2017 Sep;6(3):159-164. doi: 10.1055/s-0036-1596064. Epub 2016 Dec 5.
Right atrial (RA) or intracardiac lines are commonly used for hemodynamic monitoring in children undergoing cardiac surgery. In some institutions, these lines are used as the preferred long-term access line due to concerns for catheter-associated blood stream infections (CABSI) and catheter-related venous thrombosis with central lines in other locations. However, the rates and risk factors for CABSI and other complications are not known for RA lines. We undertook this study to estimate CABSI rates for RA lines in comparison with central catheters of various types and locations and to evaluate the incidence of other complications associated with the use of RA lines. After approval from the Institutional Review Board, a retrospective review of all patients undergoing cardiac surgery at Arkansas Children's Hospital between the dates of January 1, 2006 and December 31, 2011 was performed. Demographic data, clinical features, and outcomes were summarized on a per-patient level. Type, location of placement, and duration of all centrally placed catheters as well as associated complications were recorded. Central venous lines (CVL) used in our unit include peripherally inserted central catheters (PICC) lines, and antibiotic and heparin coated double or triple lumen lines placed in internal jugular (IJ), femoral (Fem), or RA positions. The data were analyzed using statistical software STATA/MP. A total of 2,736 central lines were used in 1,537 patients. Data on line duration, alteplase use, and percentage of lines developing CABSI are described in the study. Disease severity as assessed by risk-adjusted classification for congenital heart surgery (RACHS) score ( < 0.046), year of placement ( < 0.001), and line type adjusted for thrombolytic (alteplase) use are significantly associated with risk of any CABSI. Overall, IJ and RA lines had least risk of CABSI while PICC lines had the highest CABSI rates. RA lines are also associated with other medically significant complications. The CABSI rates associated with RA lines are lower than those seen with PICC lines. However, RA line use is associated with other, potentially significant complications. RA lines may be used cautiously as long-term access lines in cardiac patients in whom it is important to preserve venous patency for future interventions.
右心房(RA)或心内导管常用于心脏手术患儿的血流动力学监测。在一些机构中,由于担心其他部位中心静脉导管相关的血流感染(CABSI)和导管相关静脉血栓形成,这些导管被用作首选的长期通路。然而,RA导管发生CABSI及其他并发症的发生率和危险因素尚不清楚。我们开展这项研究以估计RA导管与各种类型和部位的中心导管相比的CABSI发生率,并评估与使用RA导管相关的其他并发症的发生率。
在获得机构审查委员会批准后,对2006年1月1日至2011年12月31日期间在阿肯色州儿童医院接受心脏手术的所有患者进行了回顾性研究。在个体患者层面总结人口统计学数据、临床特征和结局。记录所有中心静脉导管的类型、放置部位和持续时间以及相关并发症。我们科室使用的中心静脉导管(CVL)包括外周静脉穿刺中心静脉导管(PICC)、放置于颈内静脉(IJ)、股静脉(Fem)或RA部位的抗生素和肝素涂层双腔或三腔导管。使用统计软件STATA/MP对数据进行分析。
1537例患者共使用了2736根中心静脉导管。研究中描述了导管持续时间、阿替普酶使用情况以及发生CABSI的导管百分比的数据。经先天性心脏病手术风险调整分类(RACHS)评分评估的疾病严重程度(<0.046)、放置年份(<0.001)以及根据溶栓药物(阿替普酶)使用情况调整的导管类型与任何CABSI风险显著相关。总体而言,IJ导管和RA导管发生CABSI的风险最低,而PICC导管的CABSI发生率最高。RA导管还与其他具有医学意义的并发症相关。
与RA导管相关的CABSI发生率低于PICC导管。然而,使用RA导管与其他潜在的严重并发症相关。对于需要保留静脉通畅以便未来进行干预的心脏病患者,RA导管可谨慎用作长期通路。